DCAT Week 2024 Patrick Thiaville, Chief Technology Officer, Exothera Nucleic Acids

We had the great pleasure of sitting down with Patrick to talk about Exothera, a remarkable company that is part of the prestigious Univercells Group. Univercells is a global leader in the field of life sciences, with a mission to make biologics accessible to all. Renowned for their ability to create rapidly scalable and affordable biologics production solutions, Univercells has been instrumental in addressing long-standing limitations within the biomanufacturing industry.

In March 2020, Univercells launched Exothera as a contract development and manufacturing organization (CDMO) specifically focused on supporting cell and gene therapy developers. With their unwavering dedication to advancing the field of biopharmaceuticals, Exothera has quickly established itself as a vital player in the industry.

Join our conversation with Patrick, where we explore the fascinating work being done at Exothera. Discover how their expertise and innovative solutions are shaping the future of cell and gene therapy development, as we uncover the unique contributions Exothera brings to the Univercells family.

Leave a comment

Your email address will not be published. Required fields are marked *